12/06/2012 - 4:10pm

Pharmacy benefit manager Catamaran Corp. has opened a new "Center of Excellence" in downtown Indianapolis, the company said Thursday.

12/05/2012 - 3:21pm

Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant.

12/04/2012 - 1:54pm

The influenza season is officially underway as flu incidence is already above the national threshold, Thomas Frieden, director of the Centers for Disease Control and Prevention, told reporters during a teleconference Monday.

12/04/2012 - 11:28am

The Food and Drug Administration will review an acid-reflux drug made by Eisai for use in children, the drug maker said.

11/30/2012 - 1:13pm

Increasing the prescriptions filled by Medicare beneficiaries by 1% would reduce the program's spending on medical services by about 0.2% by reducing costs in such areas as hospitalizations, according to a new report by the Congressional Budget Office.

11/30/2012 - 11:43am

The Food and Drug Administration has approved a new drug made by Exelixis for treating thyroid cancer, the agency said.

11/29/2012 - 5:20pm

Generic Pharmaceutical Association president and CEO Ralph Neas called it “the most important pharmaceutical legislation since the 1984 Hatch-Waxman Act.” John Castellani, president and CEO of the Pharmaceutical Research and Manufacturers of America, said the law served “the best interests of America’s patients.”


11/29/2012 - 5:20pm

In 2011 and 2012, the steady surge of blockbuster pharmaceuticals falling off the patent cliff became a stampede. An astonishing number of big-selling drugs that had established and sustained branded drug makers’ profits for years fell victim to the expiration of their patent lives and market exclusivity, roiling the pharmaceutical marketplace and redefining the pricing model for many of the most widely prescribed classes of medicines.


11/29/2012 - 5:20pm

The Obama administration’s ambitious overhaul of the nation’s healthcare system weathered some significant challenges in 2012 and came through relatively unscathed.